Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.2 replacing v3.3.1. No substantive changes to the study record or visible content are shown.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page footer.
    Difference
    0.0%
    Check dated 2025-11-24T13:20:02.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page; the rest of the record history and trial details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:28:42.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The Record History page displays a redesigned layout and updated styling for the version list, while the underlying version data remains unchanged.
    Difference
    0.0%
    Check dated 2025-11-03T01:10:22.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    8%
    Check dated 2025-10-05T09:29:21.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:09:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.